Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intra-arterially Delivered Autologous Mesenchymal Stem/Stromal Cell Therapy in Patients With Diabetic Kidney Disease: A Phase I Study

NCT03840343 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT03840343
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03840343 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intra-arterially Delivered Autologous Mesenchymal Stem/Stromal Cell Therapy in Patients With Diabetic Kidney Disease: A Phase I Study
Lead sponsor
Mayo Clinic
Phase
Phase 1
Overall status
Terminated
Start date
October 23, 2019
Completion date
August 4, 2020
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease, diabetes mellitus, type 1, diabetes mellitus, type 2, diabetic kidney disease, diabetic nephropathies, diabetic nephropathy type 2, kidney failure, kidney insufficiency